MedPath
NMPA Approval

Insulin Detemir Injection

S20140045

September 5, 2019

S20140045

Drug Information

地特胰岛素注射液

诺和平

诺和平

注射剂

3ml:300单位(特充)

生物制品

September 5, 2019

September 4, 2024

Company Information

Applicant Company

Novo Nordisk A/S

Novo Alle, DK-2880 Bagsvaerd, Denmark

Manufacturing Company

Novo Nordisk A/S

Novo Alle,DK-2880 Bagsvaerd,Denmark

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

地特胰岛素注射液 - NMPA 批准文号 | MedPath